OROS Methylphenidate in Adolescents with ADHD

Abstract

The efficacy and tolerability of osmotic-release oral system (OROS) methylphenidate in adolescents with attention deficit hyperactivity disorder (ADHD) were evaluated in a multisite controlled study at the Massachusetts General Hospital, Boston, and other centers in the United States.

Keywords

• osmotic-release oral system
• attention deficit hyperactivity disorder
• methylphenidate